Published in J Virol on August 01, 1996
Simian varicella virus in pigtailed macaques (Macaca nemestrina): clinical, pathologic, and virologic features. Comp Med (2009) 1.14
Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol (2007) 1.04
Simian varicella in old world monkeys. Comp Med (2008) 1.02
Varicella-zoster virus open reading frame 21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency. J Virol (2003) 1.01
Varicella-zoster virus gene 21: transcriptional start site and promoter region. J Virol (1998) 0.93
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
Varicella-zoster virus transcription in human trigeminal ganglia. Virology (1993) 2.63
Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol (1995) 2.58
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41
Regulation of varicella-zoster virus gene expression in human T lymphocytes. J Virol (1992) 2.12
Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68
Recent studies on the isolation and characterization of Delta herpesvirus. Lab Anim Sci (1974) 1.54
Retention of the herpes simplex virus type 1 (HSV-1) UL37 protein on single-stranded DNA columns requires the HSV-1 ICP8 protein. J Virol (1994) 1.52
The UL37 protein of herpes simplex virus type 1 is associated with the tegument of purified virions. Virology (1995) 1.42
The herpes simplex virus UL37 protein is phosphorylated in infected cells. J Virol (1993) 1.41
The untranslated regions of beta-globin mRNA evolve at a functional rate in higher primates. Cell (1981) 1.35
Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide. J Virol (1988) 1.35
Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infect Immun (1977) 1.27
Immunological relationship between delta herpesvirus of patas monkeys and varicells-zoster virus of humans. Infect Immun (1975) 1.23
Simian varicella virus DNA in dorsal root ganglia. Proc Natl Acad Sci U S A (1991) 1.11
The simian varicella virus and varicella zoster virus genomes are similar in size and structure. Virology (1992) 1.08
Simian varicella virus: characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus. J Gen Virol (1992) 1.05
Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology (1992) 1.02
Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab Invest (1992) 0.97
Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. J Med Virol (1987) 0.96
Varicella-zoster virus immunizes patas monkeys against simian varicella-like disease. J Gen Virol (1979) 0.96
DNA sequence and genetic organization of the unique short (US) region of the simian varicella virus genome. Virology (1993) 0.92
The genomes of simian varicella virus and varicella zoster virus are colinear. Virus Res (1992) 0.92
Molecular analysis of simian varicella virus DNA. Virology (1992) 0.92
Varicella-like herpesvirus infections of nonhuman primates. Lab Anim Sci (1986) 0.82
DNA sequence of a simian varicella virus gene that encodes a homologue of varicella zoster virus IE62 and herpes simplex virus ICP4. Virology (1993) 0.78
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology (2007) 2.76
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Varicella-zoster virus DNA in human sensory ganglia. Nature (1984) 2.34
Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med (2001) 2.18
Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology (2000) 1.84
Search for varicella zoster virus in giant cell arteritis. Ann Neurol (1998) 1.78
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol (1995) 1.66
The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol (2001) 1.65
Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol (1992) 1.65
Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64
Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol (1998) 1.59
Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58
Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J Infect Dis (1992) 1.52
Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38
Something particular in the air we breathe? Med J Aust (1998) 1.38
The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36
Isolation of Herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet (1977) 1.30
Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol (1999) 1.28
Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol (1999) 1.25
Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol (1996) 1.25
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
Zoster myelitis: improvement with antiviral therapy in two cases. Neurology (1996) 1.19
Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol (1995) 1.18
Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab Invest (1977) 1.18
Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult Scler (2004) 1.15
The patterns of varicella zoster virus encephalitis. Hum Pathol (1996) 1.15
Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia. Proc Natl Acad Sci U S A (1988) 1.14
Configuration of latent varicella-zoster virus DNA. J Virol (1995) 1.12
The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci (1986) 1.12
Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology (2007) 1.12
Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis (1992) 1.12
Cerebellar hypoplasia in neonatal rats caused by lymphocytic choriomeningitis virus. Science (1971) 1.09
Trans-activation of viral tk promoters by proteins encoded by varicella zoster virus open reading frames 61 and 62. Virus Res (1990) 1.07
Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A (1988) 1.05
Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology (2001) 1.04
The production of varicella Zoster virus antiserum in laboratory animals. Brief report. Arch Virol (1982) 1.03
Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology (1992) 1.02
An animal model of varicella virus infection. Brain Pathol (2001) 1.01
A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Arch Virol (1983) 1.01
The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes. Clin Immunol (2001) 1.01
Infectious simian varicella virus expressing the green fluorescent protein. J Neurovirol (1998) 0.99
Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab Invest (1992) 0.97
The problems of latent varicella zoster virus in human ganglia: precise cell location and viral content. J Neurovirol (1999) 0.96
Varicella-zoster virus infection of human brain cells and ganglion cells in tissue culture. Arch Virol (1978) 0.96
Varicella-zoster virus gene 21: transcriptional start site and promoter region. J Virol (1998) 0.93
Experimental panencephalitis induced in suckling mice, by parainfluenza type 1 (6/94) virus, II. Virologic studies. J Neuropathol Exp Neurol (1976) 0.93
Profound cerebrospinal fluid pleocytosis and Froin's Syndrome secondary to widespread necrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis. J Neurol Sci (1998) 0.92
Human brain in tissue culture. III. PML-SV40-induced transformation of brain cells and establishment of permanent lines. J Comp Neurol (1975) 0.92
Molecular analysis of simian varicella virus DNA. Virology (1992) 0.92
Human herpesvirus latency. Brain Pathol (2001) 0.91
Chlamydia: a role for multiple sclerosis or more confusion? Ann Neurol (1999) 0.91
Human brain in tissue culture. IV. Morphological characteristics. J Comp Neurol (1975) 0.91
Detection of antibodies to varicella-zoster virus proteins in sera from the elderly. Gerontology (1988) 0.91
MHV-A59 pathogenesis in mice. Adv Exp Med Biol (1984) 0.90
Herpes zoster with postherpetic neuralgia--persisting pain and frustration. N Engl J Med (1994) 0.90
The effect of neonatal thymectomy on Tamiami virus-induced central nervous system disease. J Neuropathol Exp Neurol (1975) 0.88
Localization of varicella-zoster virus gene 21 protein in virus-infected cells in culture. J Virol (1998) 0.88
Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis (2011) 0.87
Extraction and purification of active IgG from SSPE and MS brain. J Virol Methods (1997) 0.86
Configuration and terminal sequences of the simian varicella virus genome. Virology (1995) 0.86
The internal organization of the varicella-zoster virus genome. J Gen Virol (1982) 0.86
Growth of the WW strain of Theiler virus in mouse central nervous system organotypic culture. Acta Neuropathol (1979) 0.86
Varicella-zoster virus: a re-emerging infection. J Investig Dermatol Symp Proc (2001) 0.86
Virology and histopathology of the trigeminal ganglia of Americans and Japanese. Can J Neurol Sci (1978) 0.85
Human brain in tissue culture. Part. 5. Identification of glial cells by immunofluorescence. J Neurol Sci (1976) 0.85
Hydrocephalus produced by the 6/94 virus; A parainfluenza type 1 isolate from multiple sclerosis brain tissue. Arch Neurol (1975) 0.84
Numbers of neurons and non-neuronal cells in human trigeminal ganglia. Neurol Res (2000) 0.84
Morphological studies of hamster brain cells transformed in vitro by a human papovavirus BK. Acta Neuropathol (1978) 0.84
Demonstration of JC virus by immunofluorescence in multiple cell types in experimentally infected adult human brain cell cultures. J Neurol Sci (1982) 0.84
Human brain in tissue culture. I. Acquisition, initial processing, and establishment of brain cell cultures. J Comp Neurol (1975) 0.83
Relapsing demyelinating disease after chicken pox in a child. Neurology (2006) 0.83
Periodic muscle weakness, normokalemia, and tubular aggregates. Neurology (1972) 0.83
Brown-Séquard syndrome after herpes zoster. Neurology (2009) 0.82
The molecular genetics of herpes simplex virus latency and pathogenesis: a puzzle with many pieces still missing. J Neurovirol (1996) 0.81
MRI abnormalities in chronic active varicella zoster infection. Neurology (2004) 0.81
Human brain in tissue culture. II. Studies of long-term cultures. J Comp Neurol (1975) 0.81
Evolution of cerebral abscess: correlation of clinical features with computed tomography. A case report. Neurology (1977) 0.81
Epstein-Barr virus--associated acute autonomic neuropathy. Ann Neurol (1996) 0.81
Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Arch Virol (1983) 0.80
Acute demyelinating disease in a chimpanzee three years after inoculation of brain cells from a patient with MS. Ann Neurol (1979) 0.79
The use of vesicular stomatitis (visna virus) pseudotypes to demonstrate visna virus receptors in cells from different species. Arch Virol (1981) 0.79
Canine distemper virus infection of weanling mice. Pathogenesis of CNS disease. J Neurol Sci (1982) 0.79